Background. Limited laboratory capacity is a significant bottleneck in meeting global targets for the control and elimination of neglected tropical diseases (NTD). Laboratories are essential for providing clinical data and monitoring data about the status and changes in NTD prevalence, and for detecting early drug resistance. Currently NTD laboratory networks are informal and specialist laboratory expertise is not well publicised, making it difficult to share global expertise and provide training, supervision, and quality assurance for NTD diagnosis and research. This study aimed to identify laboratories within five World Health Organisation regions (South-East Asia, Eastern Mediterranean, Americas, Western Pacific and Europe) that provide ...
The World Health Organization (WHO) resolution calling on Member States to work towards achieving un...
Despite long-standing availability of an effective vaccine, tetanus remains a significant problem in...
Stakeholders in healthcare are increasingly turning to real world evidence (RWE) to inform their dec...
Background. Limited laboratory capacity is a significant bottleneck in meeting global targets for th...
Background: INTERBIO-21 st is Phase II of the INTERGROWTH-21 st Project, the population-based, resea...
In 2013, illegal drug use was responsible for 1.8% of years of life lost in the European Union, alco...
Background. Chronic pain is a common, often disabling condition thought to involve a combination of ...
Background: Mobile health (mHealth) has been hailed as a potential gamechanger for non-communicable ...
Background: While primary health care (PHC)-based prevention and management of heavy drinking is cli...
In recognition of the central importance of surveillance and epidemiology in the control of antimicr...
In recognition of the central importance of surveillance and epidemiology in the control of antimicr...
Background: With increasing insecticide resistance in malaria-endemic countries there is an urgent n...
Dupuytren’s disease is a common fibrotic condition of the hand affecting 4% of the population and ca...
Studies evaluating the impact of Xpert MTB/RIF testing for tuberculosis (TB) have demonstrated varie...
Introduction: Vaccines and drugs for the treatment and prevention of COVID-19 require robust evidenc...
The World Health Organization (WHO) resolution calling on Member States to work towards achieving un...
Despite long-standing availability of an effective vaccine, tetanus remains a significant problem in...
Stakeholders in healthcare are increasingly turning to real world evidence (RWE) to inform their dec...
Background. Limited laboratory capacity is a significant bottleneck in meeting global targets for th...
Background: INTERBIO-21 st is Phase II of the INTERGROWTH-21 st Project, the population-based, resea...
In 2013, illegal drug use was responsible for 1.8% of years of life lost in the European Union, alco...
Background. Chronic pain is a common, often disabling condition thought to involve a combination of ...
Background: Mobile health (mHealth) has been hailed as a potential gamechanger for non-communicable ...
Background: While primary health care (PHC)-based prevention and management of heavy drinking is cli...
In recognition of the central importance of surveillance and epidemiology in the control of antimicr...
In recognition of the central importance of surveillance and epidemiology in the control of antimicr...
Background: With increasing insecticide resistance in malaria-endemic countries there is an urgent n...
Dupuytren’s disease is a common fibrotic condition of the hand affecting 4% of the population and ca...
Studies evaluating the impact of Xpert MTB/RIF testing for tuberculosis (TB) have demonstrated varie...
Introduction: Vaccines and drugs for the treatment and prevention of COVID-19 require robust evidenc...
The World Health Organization (WHO) resolution calling on Member States to work towards achieving un...
Despite long-standing availability of an effective vaccine, tetanus remains a significant problem in...
Stakeholders in healthcare are increasingly turning to real world evidence (RWE) to inform their dec...